Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Drlica
Xilin Zhao

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 6, 2007
Mutant selection window hypothesis updatedKarl Drlica, Xilin Zhao
The Journal of Antimicrobial Chemotherapy|June 12, 2008
A unified anti-mutant dosing strategyXilin Zhao, Karl Drlica
The Journal of Infectious Diseases|February 28, 2002
Restricting the selection of antibiotic-resistant mutant bacteria: measurement and potential use of the mutant selection windowXilin Zhao, Karl Drlica
Current Opinion in Microbiology|August 1, 2014
Reactive oxygen species and the bacterial response to lethal stressXilin Zhao, Karl Drlica
Expert Review of Anti-Infective Therapy|October 21, 2020
Bacterial death from treatment with fluoroquinolones and other lethal stressorsKarl Drlica, Xilin Zhao
Frontiers in Cellular and Infection Microbiology|October 17, 2022
Fluoroquinolone heteroresistance, antimicrobial tolerance, and lethality enhancementAmit Singh, Xilin Zhao, Karl Drlica
The Journal of Antimicrobial Chemotherapy|November 26, 2014
Moving forward with reactive oxygen species involvement in antimicrobial lethalityXilin Zhao, Yuzhi Hong, Karl Drlica
The Lancet. Infectious Diseases|May 13, 2008
Minimising moxifloxacin resistance with tuberculosisKarl Drlica, Xilin Zhao, Barry Kreiswirth
Molecular Microbiology|June 29, 2006
Lethal fragmentation of bacterial chromosomes mediated by DNA gyrase and quinolonesMuhammad Malik, Xilin Zhao, Karl Drlica
Antimicrobial Agents and Chemotherapy|January 18, 2002
Selection of Streptococcus pneumoniae mutants having reduced susceptibility to moxifloxacin and levofloxacinXinying Li, Xilin Zhao, Karl Drlica
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 6, 2007
Mutant selection window hypothesis updatedKarl Drlica, Xilin Zhao
The Journal of Antimicrobial Chemotherapy|June 12, 2008
A unified anti-mutant dosing strategyXilin Zhao, Karl Drlica
The Journal of Infectious Diseases|February 28, 2002
Restricting the selection of antibiotic-resistant mutant bacteria: measurement and potential use of the mutant selection windowXilin Zhao, Karl Drlica
Current Opinion in Microbiology|August 1, 2014
Reactive oxygen species and the bacterial response to lethal stressXilin Zhao, Karl Drlica
Expert Review of Anti-Infective Therapy|October 21, 2020
Bacterial death from treatment with fluoroquinolones and other lethal stressorsKarl Drlica, Xilin Zhao
Frontiers in Cellular and Infection Microbiology|October 17, 2022
Fluoroquinolone heteroresistance, antimicrobial tolerance, and lethality enhancementAmit Singh, Xilin Zhao, Karl Drlica
The Journal of Antimicrobial Chemotherapy|November 26, 2014
Moving forward with reactive oxygen species involvement in antimicrobial lethalityXilin Zhao, Yuzhi Hong, Karl Drlica
The Lancet. Infectious Diseases|May 13, 2008
Minimising moxifloxacin resistance with tuberculosisKarl Drlica, Xilin Zhao, Barry Kreiswirth
Molecular Microbiology|June 29, 2006
Lethal fragmentation of bacterial chromosomes mediated by DNA gyrase and quinolonesMuhammad Malik, Xilin Zhao, Karl Drlica
Antimicrobial Agents and Chemotherapy|January 18, 2002
Selection of Streptococcus pneumoniae mutants having reduced susceptibility to moxifloxacin and levofloxacinXinying Li, Xilin Zhao, Karl Drlica
Pageof 15